UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049181
Receipt number R000055989
Scientific Title Effect of intake of Long pepper extract on quality of sleep.
Date of disclosure of the study information 2022/10/14
Last modified on 2023/04/17 11:00:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of intake of Long pepper extract on quality of sleep.

Acronym

Effect of intake of Long pepper extract on quality of sleep.

Scientific Title

Effect of intake of Long pepper extract on quality of sleep.

Scientific Title:Acronym

Effect of intake of Long pepper extract on quality of sleep.

Region

Japan


Condition

Condition

Healthy volunteer

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of intake of Long pepper extract on sleep

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sleep EEG

Key secondary outcomes

The evaluation of questionnaire on sleep quality


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of test food with Long pepper extract (for 4 consecutive days) - washout period more than 3 days - Intake of placebo food (for 4 consecutive days)

Interventions/Control_2

Intake of placebo food (for 4 consecutive days) - washout period more than 3 days - Intake of test food with Long pepper extract (for 4 consecutive days)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Japanese males and females aged over 20 years old at the time of informed consent.
2. Subjects who agree to participate in this study with a written informed consent after receiving sufficient explanation relating to this study.

Key exclusion criteria

1.Subjects who are in an environment where bedtime sleep is disturbed (such as baby, child and pet).
2. Subjects who are taking medicines and health foods related to sleep, stress, and fatigue.
3.Subjects who consistently drink more than the appropriate amount of alcohol (about 20 g of pure alcohol per day).
4. Subjects who are midnight-shift worker or shift worker.
5.Subjects who do not have a constant bedtime (more than 3 hours).
6. Subjects who do not have a constant exercise habit (in terms of high intensity exercise).
7. Subjects who do not have a constant lifestyle (such as day and night reversal).
8. Subjects who are suffering from, undergoing treatment for, or with a history of serious diseases such as diabetes, kidney / liver disease, heart disease or thyroid disease, adrenal disease, and other metabolic diseases.
9.Subjects who have chronic diseases and take medicine on a daily basis.
10. Subjects who are said to snore frequently during the night, and those who are often awakened by snoring.
11.Subjects who are smoker.
12.Subjects with implantable medical devices such as cardiac pacemakers and implantable cardioverter-defibrillators.
13.Subjects who are pregnant or breast-feeding or have the will of pregnancy during the test period.
14.Subjects who may have an allergic reaction to the test food, and subjects who may have a severe allergic reaction to other foods or medicines.
15.subjects who plan to go on a business trip (domestic or overseas) or trip (domestic or overseas) during the study period.
16. Subjects who change their sleeping environment.
17. Subjects who participate in other clinical trials, who have participated in other clinical tests within one month of obtaining consent, or who are willing to participate.
18. Subjects who are judged as unsuitable for the study by the investigator for other reasons.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name MOTOKO
Middle name
Last name TAKAOKA

Organization

Kobe College

Division name

School of Human Sciences, Department of Biosphere Sciences

Zip code

6628506

Address

4-1 Okadayama, Nhishinomiya-shi, Hyogo pref. 662-8506 Japan

TEL

0798-51-8668

Email

takaoka@mail.kobe-c.ac.jp


Public contact

Name of contact person

1st name MOTOKO
Middle name
Last name TAKAOKA

Organization

Kobe College

Division name

School of Human Sciences, Department of Biosphere Sciences

Zip code

6628506

Address

4-1 Okadayama, Nhishinomiya-shi, Hyogo pref. 662-8506 Japan

TEL

0798-51-8668

Homepage URL


Email

takaoka@mail.kobe-c.ac.jp


Sponsor or person

Institute

Kobe College

Institute

Department

Personal name



Funding Source

Organization

Maruzen Pharmaceuticals Co. Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)

Kobe College


IRB Contact (For public release)

Organization

Kobe college school of human sciences research ethics committee

Address

4-1 Okadayama, Nhishinomiya-shi, Hyogo pref. 662-8506 Japan

Tel

0798-51-8423

Email

sumi@mail.kobe-c.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸女学院大学


Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 08 Month 25 Day

Date of IRB

2022 Year 09 Month 12 Day

Anticipated trial start date

2022 Year 10 Month 17 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 11 Day

Last modified on

2023 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055989


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name